title: Impact of processing parameters on the haemocompatibility of Bombyx mori silk films.
abstract: Silk has traditionally been used for surgical sutures due to its lasting strength and durability; however, the use of purified silk proteins as a scaffold material for vascular tissue engineering goes beyond traditional use and requires application-orientated biocompatibility testing. For this study, a library of Bombyx mori silk films was generated and exposed to various solvents and treatment conditions to reflect current silk processing techniques. The films, along with clinically relevant reference materials, were exposed to human whole blood to determine silk blood compatibility. All substrates showed an initial inflammatory response comparable to polylactide-co-glycolide (PLGA), and a low to moderate haemostasis response similar to polytetrafluoroethylene (PTFE) substrates. In particular, samples that were water annealed at 25 °C for 6 h demonstrated the best blood compatibility based on haemostasis parameters (e.g. platelet decay, thrombin-antithrombin complex, platelet factor 4, granulocytes-platelet conjugates) and inflammatory parameters (e.g. C3b, C5a, CD11b, surface-associated leukocytes). Multiple factors such as treatment temperature and solvent influenced the biological response, though no single physical parameter such as β-sheet content, isoelectric point or contact angle accurately predicted blood compatibility. These findings, when combined with prior in vivo data on silk, support a viable future for silk-based vascular grafts.
authors.affiliation: Tufts University, Department of Biomedical Engineering, MA 02155, USA.
authors.forename: F Philipp
authors.initials: FP
authors.lastname: Seib
authors.forename: Manfred F
authors.initials: MF
authors.lastname: Maitz
authors.forename: Xiao
authors.initials: X
authors.lastname: Hu
authors.forename: Carsten
authors.initials: C
authors.lastname: Werner
authors.forename: David L
authors.initials: DL
authors.lastname: Kaplan
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry / Q000378:metabolism*; D012831:Bombyx / Q000737:chemistry*; D006487:Hemostasis; D006801:Humans; D019344:Lactic Acid / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D008422:Materials Testing; D011100:Polyglycolic Acid / Q000737:chemistry / Q000378:metabolism; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D047011:Silk / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*
chemical_list: D001672:Biocompatible Materials; D047011:Silk; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid
references.citation: Artif Organs. 2008 Dec;32(12):932-41
references.pmid: 19133021
references.citation: Adv Drug Deliv Rev. 2009 Oct 5;61(12):1007-19
references.pmid: 19651166
references.citation: Proc Natl Acad Sci U S A. 2011 May 31;108(22):9214-9
references.pmid: 21571635
references.citation: Circulation. 2001 Sep 25;104(13):1533-7
references.pmid: 11571248
references.citation: J Biomater Appl. 2001 Jul;16(1):68-90
references.pmid: 11475360
references.citation: Adv Mater. 2010 Jan 12;22(2):249-60
references.pmid: 20217686
references.citation: J Biomater Sci Polym Ed. 1998;9(9):905-14
references.pmid: 9747984
references.citation: J Biomed Mater Res B Appl Biomater. 2003 Jul 15;66(1):379-90
references.pmid: 12808598
references.citation: Biomaterials. 2001 Oct;22(20):2731-40
references.pmid: 11545307
references.citation: Biomaterials. 2004 Feb;25(3):377-83
references.pmid: 14585685
references.citation: Biomaterials. 2003 Aug;24(18):3079-85
references.pmid: 12895580
references.citation: J Biomed Mater Res B Appl Biomater. 2009 Jul;90(1):18-25
references.pmid: 18973273
references.citation: Biomaterials. 2004 Sep;25(21):5137-46
references.pmid: 15109837
references.citation: J Biomater Sci Polym Ed. 2009;20(13):1875-97
references.pmid: 19793445
references.citation: Biomaterials. 2007 May;28(14):2306-13
references.pmid: 17292467
references.citation: J Clin Invest. 1999 Mar;103(6):879-87
references.pmid: 10079109
references.citation: J Vasc Surg. 2010 Jan;51(1):155-64
references.pmid: 19954921
references.citation: Int Rev Cytol. 2007;262:75-150
references.pmid: 17631187
references.citation: Ophthalmology. 1984 May;91(5):479-83
references.pmid: 6377167
references.citation: Biomaterials. 2008 Mar;29(7):894-903
references.pmid: 18048096
references.citation: J Vasc Surg. 2004 Jul;40(1):146-53
references.pmid: 15218475
references.citation: Int Angiol. 1987 Jan-Mar;6(1):81-7
references.pmid: 3624952
references.citation: Biomaterials. 2007 Jun;28(16):2547-71
references.pmid: 17316788
references.citation: Biomaterials. 2005 May;26(15):2775-85
references.pmid: 15585282
references.citation: Science. 2010 Jul 30;329(5991):528-31
references.pmid: 20671180
references.citation: Tissue Eng Part B Rev. 2010 Jun;16(3):341-50
references.pmid: 20085439
references.citation: J Vasc Surg. 2004 Nov;40(5):924-31
references.pmid: 15557906
references.citation: Biomed Mater. 2008 Dec;3(4):044106
references.pmid: 19029605
references.citation: Expert Rev Med Devices. 2008 May;5(3):337-47
references.pmid: 18452384
references.citation: Biomaterials. 2009 Sep;30(27):4447-56
references.pmid: 19535136
references.citation: J Biomed Mater Res A. 2007 Sep 1;82(3):740-6
references.pmid: 17326229
references.citation: Biomaterials. 2004 Nov;25(26):5681-703
references.pmid: 15147815
references.citation: Biomacromolecules. 2011 May 9;12(5):1686-96
references.pmid: 21425769
references.citation: Prog Polym Sci. 2007;32(8-9):991-1007
references.pmid: 19543442